Osaic Holdings
NPCE icon

Osaic Holdings’s Neuropace NPCE Stock Holding History

Osaic Holdings’s Portfolio NPCE Stock Details NPCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.1K Buy
+84
New +$1.26K ﹤0.01% 7236
2024
Q1 		– Sell
-233
Closed -$2.4K – 7334
2023
Q4 		$2.4K Buy
+233
New +$1.86K ﹤0.01% 6473
2022
Q1 		– Sell
-145
Closed -$1K – 7410
2021
Q4 		$1K Sell
145
-600
-81% -$7.79K ﹤0.01% 7218
2021
Q3 		$12K Buy
745
+45
+6% +$945 ﹤0.01% 6094
2021
Q2 		$17K Buy
+700
New +$16.2K ﹤0.01% 5753

Other funds holding NPCE

PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Osaic Holdings's NPCE Position: Q1 2026 in Review

Osaic Holdings opened a new position in Neuropace (NPCE) in Q1 2026: 84 shares worth $1.1K. The stake represents ﹤0.01% of the portfolio and ranks #7236 among its holdings. This is a return to the name: Osaic Holdings previously reported a position in NPCE as recently as Q4 2023.

Osaic Holdings first reported a position in NPCE in Q2 2021 and has held it in 5 quarters since. The position peaked at $17K in Q2 2021. 113 funds tracked by Wall St. Rank hold NPCE as of Q1 2026.

  • Osaic Holdings held 84 shares of Neuropace worth $1.1K as of Q1 2026.
  • Neuropace was a new Osaic Holdings position in Q1 2026.
  • Neuropace made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #7236 holding.
  • Osaic Holdings first reported a position in Neuropace in Q2 2021 and has held it in 5 quarters since.
  • Osaic Holdings's Neuropace position peaked at $17K in Q2 2021.
  • 113 funds tracked by Wall St. Rank held Neuropace as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.